搜索临床试验以:osimertinib
总计287个结果
-
Michael HoppBoehringer Ingelheim主动,不招人
-
Boehringer Ingelheim完全的
-
University of Colorado, DenverCancer League of Colorado完全的
-
Oslo University HospitalAstraZeneca主动,不招人肺癌 | 靶向治疗瑞典, 芬兰, 丹麦, 立陶宛, 挪威
-
First Affiliated Hospital of Zhejiang UniversityAstraZeneca主动,不招人
-
First Affiliated Hospital of Zhejiang University终止
-
AstraZenecaQuintiles, Inc.完全的
-
The Netherlands Cancer InstituteRoche Pharma AG; AstraZeneca终止
-
Academisch Ziekenhuis MaastrichtThe Netherlands Cancer Institute; ZonMw: The Netherlands Organisation for Health Research and...完全的
-
European Organisation for Research and Treatment...AstraZeneca主动,不招人
-
ETOP IBCSG Partners FoundationHoffmann-La Roche; AstraZeneca主动,不招人非小细胞肺癌转移爱尔兰, 新加坡, 西班牙, 瑞士, 大韩民国, 荷兰
-
Ukrainian Medical Stomatological Academy完全的
-
Chul KimBristol-Myers Squibb; AstraZeneca; Walter Reed National Military Medical Center; Hackensack Meridian...主动,不招人
-
AstraZenecaParexel完全的肺癌加拿大, 丹麦, 意大利, 西班牙, 比利时, 大韩民国, 巴西, 中国, 台湾, 澳大利亚, 奥地利, 英国, 瑞典, 阿根廷, 沙特阿拉伯, 爱尔兰
-
Seoul National University HospitalAstraZeneca; Korean Cancer Study Group完全的
-
Fondazione Policlinico Universitario Agostino Gemelli...完全的
-
Samsung Medical Center主动,不招人EGFR T790M 突变的非小细胞肺癌 | 有脑和/或软脑膜转移 | 失败的酪氨酸激酶抑制剂大韩民国
-
Chonnam National University Hospital完全的
-
Vanderbilt University Medical CenterNational Heart, Lung, and Blood Institute (NHLBI)完全的
-
Manimarane Arjunan, MD,DM (Cardiology)UR Anoop Research Group完全的
-
Seoul St. Mary's HospitalBoehringer Ingelheim主动,不招人
-
Asan Medical CenterAstraZeneca完全的
-
University of ChicagoNational Institute of Mental Health (NIMH)完全的
-
AstraZeneca完全的
-
Shanghai JMT-Bio Inc.CSPC ZhongQi Pharmaceutical Technology Co., Ltd.未知
-
Shanghai Cancer Hospital, China未知肺癌IV期,EGFR突变,TKI,PD-L1,SBRT中国
-
Guangzhou Institute of Respiratory DiseaseShanghai Junshi Bioscience Co., Ltd.未知具有 T790M 阳性突变的 IIIb/IV NSCLC 奥希替尼治疗失败中国
-
Second Affiliated Hospital of Nanchang UniversityNanchang University未知
-
Sungkyunkwan UniversityMinistry of Food and Drug Safety, Korea未知癌,非小细胞肺癌 | 免疫相关不良事件